These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8440160)

  • 21. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J; Lalonde G; Bichet D; Rouleau JL
    Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of one-year treatment with captopril on exercise tolerance and myocardial ischemia in patients with myocardial infarction ].
    Wierzchowiecki M; Filipiak J; Poprawski K; Ozegowski S; Szymanowska K; Sieńko A
    Pol Merkur Lekarski; 2000 Aug; 9(50):536-40. PubMed ID: 11081319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled clinical studies of tolerance development and dosing problems in nitrate therapy].
    Abshagen U
    Herz; 1996 Jun; 21 Suppl 1():23-30. PubMed ID: 8767921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
    Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
    Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
    Rudolph W; Dirschinger J; Kraus F; Reiniger G; Hall D
    Z Kardiol; 1990; 79 Suppl 3():57-65. PubMed ID: 2099042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure.
    Vacek JL; Handlin LR; Beaufort CJ; Koenig CA
    Coron Artery Dis; 1993 Dec; 4(12):1109-13. PubMed ID: 8162243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
    Vogler AC; Silber S; Spiegelsberger F; Theisen K
    Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does captopril possess antianginal actions? An evaluation of its effects on myocardial ischemia by stress tests in patients with stable angina and normal ventricular function].
    Poveda Sierra JJ; Berrazueta JR; Ochoteco A; Salas E
    Rev Esp Cardiol; 1993 Oct; 46(10):642-7. PubMed ID: 8234999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Silent myocardial ischemia and nitrates].
    Palma Gámiz JL
    Ann Cardiol Angeiol (Paris); 1997; 46(7):431-40. PubMed ID: 9452778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute and subchronic effect of a patch with discontinuous nitroglycerin liberation].
    Schirnick C; Reifart N
    Z Kardiol; 1989; 78 Suppl 2():79-82; discussion 115-7. PubMed ID: 2511698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Digitalis effects on the electrocardiogramm: ergometric studies in healthy subjects and patients with coronary artery disease (author's transl)].
    Lehmann HU; Janitzki S; Hochrein H
    Dtsch Med Wochenschr; 1977 Sep; 102(38):1335-41. PubMed ID: 902604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitrate tolerance--a therapeutic dilemma.
    Sharpe N
    Int J Cardiol; 1988 Dec; 21(3):207-10. PubMed ID: 3147948
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nitrate plaster: duration of effect--loss of effect. Deliberations on the mechanism of activity of nitrate].
    Bussmann WD
    Dtsch Med Wochenschr; 1989 Dec; 114(51-52):2023-6. PubMed ID: 2689131
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic value of bicycle ergometry in medically treated patients with three-vessel coronary artery disease.
    Jánosi A; Tarján Z
    Chest; 1988 Jul; 94(1):171-2. PubMed ID: 3383629
    [No Abstract]   [Full Text] [Related]  

  • 37. New aspects of nitrate therapy in coronary artery disease.
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S1-76. PubMed ID: 2354711
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
    Störk T; Eichstädt H; Möckel M; Gareis R; Bodemann T; Müller R
    Clin Cardiol; 1997 Dec; 20(12):999-1004. PubMed ID: 9422837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
    Plosker GL; McTavish D
    Drugs Aging; 1995 Sep; 7(3):226-53. PubMed ID: 8535052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of captopril in nitrate tolerance].
    Bussmann WD; Felsinger K
    Dtsch Med Wochenschr; 1993 Feb; 118(7):209-12. PubMed ID: 8440160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.